CRL - Company ID 0001100682
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported revenue of $4.02B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $4.02B | -0.9% |
| FY 2024 | $4.05B | -1.9% |
| FY 2023 | $4.13B | +3.9% |
| FY 2022 | $3.98B | +12.3% |
| FY 2021 | $3.54B | +21.1% |
| FY 2020 | $2.92B | +11.5% |
| FY 2019 | $2.62B | +15.7% |
| FY 2018 | $2.27B | +22.0% |
| FY 2017 |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported revenue of $4.02B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s revenue grew from $1.14B to $4.02B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.86B |
| +10.5% |
| FY 2016 | $1.68B | +23.3% |
| FY 2015 | $1.36B | +5.1% |
| FY 2014 | $1.30B | +11.3% |
| FY 2013 | $1.17B | +3.2% |
| FY 2012 | $1.13B | -1.1% |
| FY 2011 | $1.14B | - |